medvisМедицинская визуализацияMedical Visualization1607-07632408-9516RDS-Media Ltd.10.24835/1607-0763-2018-1-78-92medvis-510Research ArticleБРЮШНАЯ ПОЛОСТЬABDOMENУРОТЕЛИАЛЬНЫЙ РАК ВЕРХНИХ МОЧЕВЫХ ПУТЕЙ: МОРФОЛОГИЯ, ДИАГНОСТИКА И ЛЕЧЕНИЕUPPER TRACT UROTHELIAL CARCINOMA: MORPHOLOGY, DIAGNOSTICS AND TREATMENTСтепановаЮ. А.StepanovaYu. A.

Степанова Юлия Александровна – доктор медицинских наук, старший научный сотрудник отдела лучевых методов диагностики и лечения  ИХ им. А.В. Вишневского; профессор кафедры лучевой диагностики ИПО ПМГМУ им. И.М. Сеченова.

117997 Москва, ул. Б. Серпуховская, 27, +7-499-236-44-14

Yulia A. Stepanova – doct. of med. sci., the senior research of radiology methods of diagnostics and treatment department of A.V. Vishnevsky IS; professor of radiology department of IPE of I.M. Sechenov First MSMU.

117997 Moscow, Bol. Serpukhovskaya str., 27, +7-499-236-44-14

stepanovaua@mail.ruПрокофьеваА. В.ProkofievaA. V.

Прокофьева Анастасия Валерьевна – ординатор кафедры лучевой диагностики ИПО.

Москва

Anastasiya V. Prokofieva – Ph-student of radiology department of IPE of I.M. Sechenov First MSMU.

Moscow

ДунаевС. А.DunaevS. A.

Дунаев Сайхан Абдурахманович – ассистент кафедры факультетской хирургии.

Грозный

Saikhan A. Dunaev – assistant of the Faculty Surgery Department.

Grozny

ГлотовА. В.GlotovA. V.

Глотов Андрей Вячеславович – младший научный сотрудник отделения патологической анатомии.

Москва

Andrey V. Glotov – the junior researcher of Patological Anatomy Department.

Moscow

МорозоваМ. В.MorozovzM. V.

Морозова Мария Владимировна – аспирант отдела лучевой диагностики.

Москва

Mariya V. Morozova – graduate student of radiology department.

Moscow

ГрицкевичА. А.GritskevichA. A.

Грицкевич Александр Анатольевич – доктор медицинских наук, старший научный сотрудник отделения урологии.

Москва

Aleksandr A. Gritskevich – cand. of med. sci, the senior research of the Urology department.

Moscow

ТепловА. А.TeplovА. А.

Теплов Александр Александрович – доктор медицинских наук, профессор, заместитель директора.

Aleksandr A. Teplov – doct. of med. sci., professor, Deputy Director.

Moscow

ФГБУ “Институт хирургии им. А.В. Вишневского” Минздрава России; ФГАОУ ВО “Первый Московский государственный медицинский университет им. И.М. Сеченова” Минздрава России (Сеченовский Университет)РоссияA.V. Vishnevsky Institute of Surgery; I.M. Sechenov First Moscow State Medical University under the Ministry of Health of the Russian Federation (I.M. Sechenov First MSMU)Russian FederationФГАОУ ВО “Первый Московский государственный медицинский университет им. И.М. Сеченова” Минздрава России (Сеченовский Университет)РоссияI.M. Sechenov First Moscow State Medical University under the Ministry of Health of the Russian Federation (I.M. Sechenov First MSMU)Russian FederationФГБОУ ВО Чеченский государственный университетРоссияChechen State UniversityRussian FederationФГБУ “Институт хирургии им. А.В. Вишневского” Минздрава РоссииРоссияA.V. Vishnevsky Institute of SurgeryRussian Federation201828022018017892Copyright © Степанова Ю.А., Прокофьева А.В., Дунаев С.А., Глотов А.В., Морозова М.В., Грицкевич А.А., Теплов А.А., 20182018Степанова Ю.А., Прокофьева А.В., Дунаев С.А., Глотов А.В., Морозова М.В., Грицкевич А.А., Теплов А.А.Stepanova Y.A., Prokofieva A.V., Dunaev S.A., Glotov A.V., Morozovz M.V., Gritskevich A.A., Teplov А.А.This work is licensed under a Creative Commons Attribution 4.0 License.https://medvis.vidar.ru/jour/article/view/510

Уротелиальная карцинома – это злокачественная опухоль, которая развивается из клеток слизистой уротелия и может выявляться как в верхних отделах мочевых путей (почечно-лоханочной системе и мочеточнике), так и в нижних отделах (мочевом пузыре и уретре). Уротелиальный рак верхних мочевых путей (УРВМП) встречается довольно редко и составляет 5–10% от всех случаев уротелиального рака. УРВМП остается до конца неизученным, имея на сегодняшний день две равноправные теории происхождения. Несмотря на современное рентгенологическое и эндоскопическое оборудование, ввиду скудных и достаточно обобщенных (сходных с другими заболеваниями) клинических проявлений, особенно на начальных стадиях болезни, необходимо постоянно совершенствовать методы диагностики для выявления недуга как можно раньше. Уже сегодня благодаря новым технологиям диагностики и лечения можно выявить болезнь на разных стадиях и продлить жизнь пациентам с УРВМП. В статье представлены данные о морфологии, клинике, диагностике и современных методах лечения данной патологии.

Urothelial carcinoma is a malignant tumor that develops from the cells of the urothelium mucosa and can be detected both in the upper parts of the urinary tract (renal and pelvic system and ureter) and in the lower parts (bladder and urethra). Urothelial cancer of the upper urinary tract (UCUUT) is quite rare and accounts for 5–10% of all cases of urothelial cancer. UCUUT remains completely unexplored, having to date two equal theories of origin. Despite the modern radiology and endoscopic equipment, in view of the meager and sufficiently generalized  clinical manifestations (similar to other diseases), especially at the initial stages of the disease, it is necessary to constantly improve diagnostic methods for detecting the disease as early as possible. Already today, thanks to new technologies for diagnosis and treatment, it is possible to identify the disease at different stages and extend life to patients with UCUUT. The article presents data on morphology, clinic, diagnostics and modern methods of treatment of this pathology.

уротелиальный ракверхние мочевые путиморфологияклиникадиагностика и лечениеupper tract urothelial carcinomamorphologyclinicdiagnosticstreatmentReferencesMukamel E., Simon D., Edelman A., Konichezky M., Hadar H., Servadio C. Metachronous bladder tumors in patients with upper urinary tract transitional cell carcinoma. J. Surg. Oncol. 1994; 57: 187–190.Mukamel E., Simon D., Edelman A., Konichezky M., Hadar H., Servadio C. Metachronous bladder tumors in patients with upper urinary tract transitional cell carcinoma. J. Surg. Oncol. 1994; 57: 187–190.Munoz J.J., Ellison L.M. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J. Urol. 2000; 164: 1523–1525.Munoz J.J., Ellison L.M. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J. Urol. 2000; 164: 1523–1525.Zigeuner R.E., Hutterer G., Chromecki T., Rehak P., Langner С. Bladder tumour Development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int. 2006; 98: 1181–1186. DOI: 10.1111/j.1464-410X.2006.06519.x.Zigeuner R.E., Hutterer G., Chromecki T., Rehak P., Langner С. Bladder tumour Development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int. 2006; 98: 1181–1186. DOI: 10.1111/j.1464-410X.2006.06519.x.Ploeg M., Aben K.K., Kiemeney L.A. The presentand future burden of urinary bladder cancer in the world. Wld J. Urol. 2009; 27: 289–293. DOI: 10.1007/s00345-009-0383-3.Ploeg M., Aben K.K., Kiemeney L.A. The presentand future burden of urinary bladder cancer in the world. Wld J. Urol. 2009; 27: 289–293. DOI: 10.1007/s00345-009-0383-3.Petkovic S., Mutavdzic M., Petronic V.L., Markovic V. Tumors of the renal pelvis and ureter: clinical and etiologic studies. J. Urol. Nephrol. 1971; 77: 429.Petkovic S., Mutavdzic M., Petronic V.L., Markovic V. Tumors of the renal pelvis and ureter: clinical and etiologic studies. J. Urol. Nephrol. 1971; 77: 429.Roupret M., Zigeuner R., Palou J., Boehle A., Kaasinen E., Sylvester R., Babjuk M., Oosterlinck W. Опухоли верхних мочевыводящих путей: Пер. Черняев В.А., науч. ред. Иванов С.А. М.: Европейская ассоциация урологов, 2011. 18 с.Roupret M., Zigeuner R., Palou J., Boehle A., Kaasinen E., Sylvester R., Babjuk M., Oosterlinck W. Tumors of the upper urinary tract: Trans. Chernyaev V.A., scien. ed. Ivanov S.A. M.: European Association of Urology, 2011. 18 p. (In Russian)Fang D., Li X.-S., Xiong G.-Y., Yao L., He Z.-S., Zhou L.-Q. Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis. Urol. Int. 2013; 91: 291–296. DOI: 10.1016/j.jfma.2013.11.004.Fang D., Li X.-S., Xiong G.-Y., Yao L., He Z.-S., Zhou L.-Q. Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis. Urol. Int. 2013; 91: 291–296. DOI: 10.1016/j.jfma.2013.11.004.Волкова М.И., Матвеев В.Б., Медведев С.В., Носов Д.А., Хмелевский Е.В., Черняев В.А. Клинические рекомендации по диагностике и лечению больных с опухолями верхних мочевыводящих путей. М.: Ассоциация онкологов России, 2014. 15 с.Volkova M.I., Matveev V.B., Medvedev S.V., Nosov D.A., Khmelevsky E.V., Chernyaev V.A. Clinical recommendations for the diagnosis and treatment of patients with tumors of the upper urinary tract. Moscow: Association of Oncologists of Russia, 2014. 15 p. (In Russian)Yuan H., Chen X., Liu L., Yang L., Pu C., Li J., Bai Y., Han P., Wei Q. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: A meta-analysis. Urologic Oncology: Sem. Original Invest. 2014; 32: 989–1002 DOI: 10.1007/s11255-017-1510-5.Yuan H., Chen X., Liu L., Yang L., Pu C., Li J., Bai Y., Han P., Wei Q. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: A meta-analysis. Urologic Oncology: Sem. Original Invest. 2014; 32: 989–1002 DOI: 10.1007/s11255-017-1510-5.Rouprêt М., Babjuk M., Compérat E., Zigeuner R., Sylvester R., Burger M., Cowan N., Böhle A., VanRhijn B.W.G., Kaasinen E., Palou J., Shariat S.F. Рекомендации по опухолям верхних мочевыводящих путей: Пер. Сиромолот Ю., науч. ред. Газмиев М.А. М.: Европейская ассоциация урологов, 2014. 20 с.Rouprêt М., Babjuk M., Compérat E., Zigeuner R., Sylvester R., Burger M., Cowan N., Böhle A., VanRhijn B.W.G., Kaasinen E., Palou J., Shariat S.F. Recomendate for tumors of the upper urinary tract. Scien. ed. Gazimiev M.A. M.: European Association of Urology, 2014. 20 p. (In Russian)Yuan H., Mao X., Bai Y., Li H., Liu L., Pu C., Li J., Tang Y., Wei Q., Han P. The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a metaanalysis. J. Chemother. 2015; 27 (4): 195–200. DOI: 10.1179/1973947815Y.0000000034.Yuan H., Mao X., Bai Y., Li H., Liu L., Pu C., Li J., Tang Y., Wei Q., Han P. The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a metaanalysis. J. Chemother. 2015; 27 (4): 195–200. DOI: 10.1179/1973947815Y.0000000034.Kuss R., Chatelain С. Surgery of the ureter. Berlin; Heidelberg; New York: Springer-Verlag, 1975. 338 p. DOI: 10.1007/978-3-642-66079-5.Kuss R., Chatelain С. Surgery of the ureter. Berlin; Heidelberg; New York: Springer-Verlag, 1975. 338 p. DOI: 10.1007/978-3-642-66079-5.Birarelli B., Morbiducci G. Clinico-radiologic contribution to the study of primary neoplasms of the ureter. Arch. Ital. Urol. 1963; 36: 3–50.Birarelli B., Morbiducci G. Clinico-radiologic contribution to the study of primary neoplasms of the ureter. Arch. Ital. Urol. 1963; 36: 3–50.Фигурин К.М. Злокачественные новообразования почечных лоханок и мочеточников. Онкоурология. 2006; 2: 5–12.Figurin K.M. Malignant neoplasms of renal pelvis and ureter. Oncourologiy. 2006; 2: 5–12. (In Russian)Пытель А.Я. I Конгресс урологов Югославии. Урология и нефрология. 1965; 2: 77–81.Pyotel A.Ya. I Congress of urologists of Yugoslavia. Urologiya i nephrologiya. 1965; 2: 77–81. (In Russian)Lughezzani G., Sun M., Perrotte P., Shariat S.F., Jeldres C., Budäus L., Latour M., Widmer H., Duclos A., Bénard F., McCormack M., Montorsi F., Karakiewicz P.I. Genderrelated differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology. 2010; 75 (2): 321–327. DOI: 10.1016/j.urology.2009.09.048.Lughezzani G., Sun M., Perrotte P., Shariat S.F., Jeldres C., Budäus L., Latour M., Widmer H., Duclos A., Bénard F., McCormack M., Montorsi F., Karakiewicz P.I. Genderrelated differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology. 2010; 75 (2): 321–327. DOI: 10.1016/j.urology.2009.09.048.Grollman A.P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., Suzuki N., Fernandes A., Rosenquist T., Medverec Z., Jakovina K., Brdar B., Slade N., Turesky R.J., Goodenough A.K., Rieger R., Vukelić M., Jelaković B. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. USA. 2007; 104 (29): 12129–12134. DOI: 10.1073/pnas.0701248104.Grollman A.P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., Suzuki N., Fernandes A., Rosenquist T., Medverec Z., Jakovina K., Brdar B., Slade N., Turesky R.J., Goodenough A.K., Rieger R., Vukelić M., Jelaković B. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. USA. 2007; 104 (29): 12129–12134. DOI: 10.1073/pnas.0701248104.Colin P., Koenig P., Ouzzane A., Berthon N., Villers A., Biserte J., Rouprêt M. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int. 2009; 104 (10): 1436–1440. DOI: 10.1111/j.1464-410X.2009.08838.x.Colin P., Koenig P., Ouzzane A., Berthon N., Villers A., Biserte J., Rouprêt M. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int. 2009; 104 (10): 1436–1440. DOI: 10.1111/j.1464-410X.2009.08838.x.Chen C.H., Dickman K.G., Moriya M., Zavadil J., Sidorenko V.S., Edwards K.L., Gnatenko D.V., Wu L., Turesky R.J., Wu X.-R., Pu Y.-S., Grollman A.P. Aristolochic acid-associated urothelial cancer in Taiwan. Proc. Natl. Acad. Sci. USA. 2012; 109 (21): 8241–8246. DOI: 10.1073/pnas.1119920109.Chen C.H., Dickman K.G., Moriya M., Zavadil J., Sidorenko V.S., Edwards K.L., Gnatenko D.V., Wu L., Turesky R.J., Wu X.-R., Pu Y.-S., Grollman A.P. Aristolochic acid-associated urothelial cancer in Taiwan. Proc. Natl. Acad. Sci. USA. 2012; 109 (21): 8241–8246. DOI: 10.1073/pnas.1119920109.Нефрология: Практическое руководство; Под ред. И.Е. Тареева. Изд. 2-е, перераб. и доп. М., Медицина:2000. 688 с.Nephrology. Practical guidance. Ed. I.E. Tareev. Ed. 2nd., processed and add. M.: Medicine, 2000. 688 p. (in Russian)Серняк П.С., Фролов А.С. Диагностика и хирургическое лечение опухолей мочеточника. Газета “Новости медицины и фармации”. 2009; 20 (300): http://www. mif-ua.com/archive/article/10885.Sernyak P.S., Frolov A.S. Diagnosis and surgical treatment of ureteral tumors. Newspaper “News of Medicine and Pharmacy”. 2009; 20 (300): http://www.mif-ua.com/ archive/article/10885. (In Russian)Moch H., Humphrey P.A., Ulbright T.M., Reuter V. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Fourth ed. Lyon, France: International Agency For Research on Cancer, 2016. 400 p.Moch H., Humphrey P.A., Ulbright T.M., Reuter V. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Fourth ed. Lyon, France: International Agency For Research on Cancer, 2016. 400 p.Seisen T., Granger B., Colin P., Léon P., Utard G., RenardPenna R., Compérat E., Mozer P., Cussenot O., Shariat S.F., Rouprêt M. A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recur rence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. Eur Urol. 2015; 67 (6): 1122–1133. DOI: 10.1016/j.eururo.2014.11.035.Seisen T., Granger B., Colin P., Léon P., Utard G., RenardPenna R., Compérat E., Mozer P., Cussenot O., Shariat S.F., Rouprêt M. A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recur rence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. Eur Urol. 2015; 67 (6): 1122–1133. DOI: 10.1016/j.eururo.2014.11.035.Habuchi T. Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int. J. Urol. 2005.; 12 (8): 709–716. DOI: 10.1111/j.1442-2042.2005.01155.x.Habuchi T. Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int. J. Urol. 2005.; 12 (8): 709–716. DOI: 10.1111/j.1442-2042.2005.01155.x.Cheng L., Cheville J.C., Neumann R.M., Bostwick D.G. Natural history of urothelial dysplasia of the bladder. Am. J. Surg. Pathol. 1999; 23: 443–447.Cheng L., Cheville J.C., Neumann R.M., Bostwick D.G. Natural history of urothelial dysplasia of the bladder. Am. J. Surg. Pathol. 1999; 23: 443–447.Takahashi T., Habuchi T., Kakehi Y., Okuno H., Terachi T., Kato T., Ogawa O. Molecular diagnosis of metastatic origin in a patient with metachronous multiple cancers of the renal pelvis and bladder. Urology. 2000; 56 (2): 331.Takahashi T., Habuchi T., Kakehi Y., Okuno H., Terachi T., Kato T., Ogawa O. Molecular diagnosis of metastatic origin in a patient with metachronous multiple cancers of the renal pelvis and bladder. Urology. 2000; 56 (2): 331.Vriesema J.L., Aben K.K., Witjes J.A., Kiemeney L.A., Schalken J.A. Superficial and metachronous invasive bladder carcinomas are clonally related. Int. J. Cancer. 2001; 93: 699–702.Vriesema J.L., Aben K.K., Witjes J.A., Kiemeney L.A., Schalken J.A. Superficial and metachronous invasive bladder carcinomas are clonally related. Int. J. Cancer. 2001; 93: 699–702.Matsui Y., Utsunomiya N., Ichioka K., Ueda N., Yoshimura K., Terai A., Arai Y. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology. 2005; 65: 279–283. DOI: 10.1016/j.urology.2004.09.021.Matsui Y., Utsunomiya N., Ichioka K., Ueda N., Yoshimura K., Terai A., Arai Y. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology. 2005; 65: 279–283. DOI: 10.1016/j.urology.2004.09.021.De Torres Mateos J.A., Banus Gassol J.M., Palou Redorta J., Morote Robles J. Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma. J. Urol. 1987; 138 (1): 49–51.De Torres Mateos J.A., Banus Gassol J.M., Palou Redorta J., Morote Robles J. Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma. J. Urol. 1987; 138 (1): 49–51.Sidransky D., Frost P., Von Eschenbach A., Oyasu R., Preisinger A.C., Vogelstein B. Clonal origin bladder cancer. N. Engl. J. Med. 1992; 326: 737–740.Sidransky D., Frost P., Von Eschenbach A., Oyasu R., Preisinger A.C., Vogelstein B. Clonal origin bladder cancer. N. Engl. J. Med. 1992; 326: 737–740.Lunec J., Challen C., Wright C., Mellon K., Neal D.E. C-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder. Lancet. 1992; 339: 439–440. DOI: 10.1016/0140-6736(92)90135-P.Lunec J., Challen C., Wright C., Mellon K., Neal D.E. C-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder. Lancet. 1992; 339: 439–440. DOI: 10.1016/0140-6736(92)90135-P.Fujimoto K., Yamada Y., Okajima E., Kakizoe T., Sasaki H., Sugimura T., Terada M. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res. 1992; 52: 1393–1308.Fujimoto K., Yamada Y., Okajima E., Kakizoe T., Sasaki H., Sugimura T., Terada M. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res. 1992; 52: 1393–1308.Steiner G., Schoenberg M.P., Linn J.F., Mao L., Sidr ansky D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat. Med. 1997; 3: 621–624.Steiner G., Schoenberg M.P., Linn J.F., Mao L., Sidr ansky D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat. Med. 1997; 3: 621–624.Takahashi T., Habuchi T., Kakehi Y., Mitsumori K., Akao T., Terachi T., Yoshida O. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res. 1998; 58: 5835–5841.Takahashi T., Habuchi T., Kakehi Y., Mitsumori K., Akao T., Terachi T., Yoshida O. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res. 1998; 58: 5835–5841.Переверзев А.С. Хирургия опухолей почки и верхних мочевых путей. Харьков: Lora Medpharm, 1997. 392 с.Pereverzev A.S. Surgery of tumors of the kidney and upper urinary tract. Kharkov: Lora Medpharm, 1997. 392 p. (In Russian)Мебель М. Опухоли почечной лоханки и мочеточника. В кн.: Клиническая урология; Под ред. Е.Б. Маринбаха. М.: Медицина, 1975: 57–66.Mebel M. Tumors of the renal pelvis and ureter. In: Clinical urology. Ed. E.B. Marinbach. M.: Medicine, 1975: 57–66. (In Russian)Johnson D.E., Babaian R.J. Conservative surgical management for non-invasive distal ureteral carcinoma. Urology. 1979; 13 (4): 365–367.Johnson D.E., Babaian R.J. Conservative surgical management for non-invasive distal ureteral carcinoma. Urology. 1979; 13 (4): 365–367.Catalona W.J. Urothelial tumours of the urinary tract. In: Walsh P.C., Retik A.B., Stamey T.A., Vaughan E.D. Jr., eds. Campbell’s Urology. 6th ed. Philadelphia, Pa, USA: W.B. Saunders. 1992. 1094 p.Catalona W.J. Urothelial tumours of the urinary tract. In: Walsh P.C., Retik A.B., Stamey T.A., Vaughan E.D. Jr., eds. Campbell’s Urology. 6th ed. Philadelphia, Pa, USA: W.B. Saunders. 1992. 1094 p.Novara G., De Marco V., Dalpiaz O., Gottardo F., Bouygues V., Galfano A., Martignoni G., Patard J.J., Artibani W., Ficarra V. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephrou reterectomy for TCC of the upper urinary tract. BJU Int. 2008; 101: 1368–1374. DOI: 10.1111/j.1464-410X.2008.07438.x.Novara G., De Marco V., Dalpiaz O., Gottardo F., Bouygues V., Galfano A., Martignoni G., Patard J.J., Artibani W., Ficarra V. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephrou reterectomy for TCC of the upper urinary tract. BJU Int. 2008; 101: 1368–1374. DOI: 10.1111/j.1464-410X.2008.07438.x.Gray Sears C.L., Ward J.F., Sears S.T., Puckett M.F, Kane C.J., Amling C.L. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J. Urol. 2002; 168: 2457–2460.Gray Sears C.L., Ward J.F., Sears S.T., Puckett M.F, Kane C.J., Amling C.L. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J. Urol. 2002; 168: 2457–2460.Joffe S.A., Servaes S., Okon S., Horowitz M.. Multi– detector row CT urography in the evaluation of hematuria. RadioGraphics. 2003; 23: 1441–1455.Joffe S.A., Servaes S., Okon S., Horowitz M.. Multi– detector row CT urography in the evaluation of hematuria. RadioGraphics. 2003; 23: 1441–1455.Kim J.K., Cho K.S. CT urography and virtual endoscopy: promising imaging modalities for urinary tract evaluation. Br. J. Radiol. 2003; 76: 199–209.Kim J.K., Cho K.S. CT urography and virtual endoscopy: promising imaging modalities for urinary tract evaluation. Br. J. Radiol. 2003; 76: 199–209.Browne R.F.J., Meehan C.P., Colville J., Power R., Torreggiani W. Transitional Cell Carcinoma of the Upper Urinary Tract: Spectrum of Imaging Findings. RadioGraphics. 2005; 25 (6): 1609–1627. DOI: 10.1148/rg.256045517.Browne R.F.J., Meehan C.P., Colville J., Power R., Torreggiani W. Transitional Cell Carcinoma of the Upper Urinary Tract: Spectrum of Imaging Findings. RadioGraphics. 2005; 25 (6): 1609–1627. DOI: 10.1148/rg.256045517.Kirkali Z., Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit. Rev. Oncol. Hematol. 2003; 47: 155–169.Kirkali Z., Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit. Rev. Oncol. Hematol. 2003; 47: 155–169.Wong-You-Cheong J.J., Wagner B.J., Davis C.J.Jr. Transitional cell carcinoma of the urinary tract: radiologicpathologic correlation. RadioGraphics. 1998; 18: 123–142.Wong-You-Cheong J.J., Wagner B.J., Davis C.J.Jr. Transitional cell carcinoma of the urinary tract: radiologicpathologic correlation. RadioGraphics. 1998; 18: 123–142.Jung P., Brauers A., Nolte-Ernsting C.A., Jakse G., Gunther R.W. Magnetic resonance urography enhanced by gadolinium and diuretics: a comparison with conventional urography in diagnosing the cause of ureteric obstruction. BJU Int. 2000; 86: 960–965.Jung P., Brauers A., Nolte-Ernsting C.A., Jakse G., Gunther R.W. Magnetic resonance urography enhanced by gadolinium and diuretics: a comparison with conventional urography in diagnosing the cause of ureteric obstruction. BJU Int. 2000; 86: 960–965.Игнашин Н.С., Перепечин Д.В. Ультразвуковая диагностика рака почечной лоханки. Тезисы VII Съезда Российской ассоциации специалистов ультразвуковой диагностики в медицине. Москва, 10–13 ноября 2015 г.; часть I: 68.Ignashin N.S., Perepechin D.V. Ultrasonic diagnosis of renal pelvis cancer. Theses of the VII Congress of the Russian Association of Specialists in Ultrasound Diagnostics in Medicine. Moscow, November 10–13, 2015; Part I: 68. (In Russian)Игнашин Н.С., Перепечин Д.В. Неинвазивная ультразвуковая диагностика рака мочеточников: Тезисы VII Съезда Российской ассоциации специалистов ультразвуковой диагностики в медицине. Москва, 10–13 ноября 2015 г.; часть I: 67–68.Ignashin N.S., Perepechin D.V. Noninvasive ultrasound diagnosis of ureteral cancer. Theses of the VII Congress of the Russian Association of Specialists in Ultrasound Diagnostics in Medicine. Moscow, November 10–13, 2015; Part I: 67–68. (In Russian)Девятовская А.Г. Дифференциальная ультразвуковая диагностика причин односторонней обструкции верхних мочевых путей: Тезисы VII Съезда Российской ассоциации специалистов ультразвуковой диагностики в медицине. Москва, 10–13 ноября 2015 г.; часть I: 50.Devyatovskaya A.G. Differential ultrasound diagnosis of the causes of unilateral obstruction of the upper urinary tract: Theses of the VII Congress of the Russian Association of Specialists in Ultrasound Diagnostics in Medicine. Moscow, November 10–13, 2015; Part I: 50. (In Russian)Амосов А.В., Крупинов Г.Е. Ультразвуковые методы функциональной диагностики в урологической практике. SonoAce International. 2000; 7: 26–30.Amosov A.V., Krupinov G.E. Ultrasonic methods of functional diagnostics in urological practice. SonoAce International. 2000; 7: 26–30. (In Russian)Зубарев А.В., Гажонова В.Е., Диагностический ультразвук. Уронефрология. М.: Реальное Время, 2002. 248 с.Zubarev A.V., Gajonova V.E. Diagnostic ultrasound. Uronefrologiya. M.: Real Times, 2002. 248 p. (In Russian)Puech P., Rouprêt M., Renard-Penna R., Lemaître L., Colin P. Imaging of urothelial carcinomas of the upper ract: state of the art review for the yearly scientific report of the National French Association of Urology. Prog Urol. 2014; 4 (15): 987–999. DOI: 10.1016/j.purol.2014.07.009.Puech P., Rouprêt M., Renard-Penna R., Lemaître L., Colin P. Imaging of urothelial carcinomas of the upper ract: state of the art review for the yearly scientific report of the National French Association of Urology. Prog Urol. 2014; 4 (15): 987–999. DOI: 10.1016/j.purol.2014.07.009.Aragon-Ching J.B. Challenges and advances in the diagnosis, biology, and treatment of urothelial upper tract and bladder carcinomas. Urol. Oncol. 2017; 35 (7): 462– 464. DOI: 10.1016/j.urolonc.2017.05.023.Aragon-Ching J.B. Challenges and advances in the diagnosis, biology, and treatment of urothelial upper tract and bladder carcinomas. Urol. Oncol. 2017; 35 (7): 462– 464. DOI: 10.1016/j.urolonc.2017.05.023.Gray Sears C.L., Ward J.F., Sears S.T., Puckett M.F, Kane C.J., Amling C.L. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J. Urol. 2002; 168: 2457–2460.Gray Sears C.L., Ward J.F., Sears S.T., Puckett M.F, Kane C.J., Amling C.L. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J. Urol. 2002; 168: 2457–2460.Лучевая диагностика: Учебник; Под ред. Г.Е. Труфанова. В 2-х томах. М.: ГЭОТАР-Медиа. 2011; Т. 1. 416 с.Radiation diagnostics: a textbook. Ed. G.E. Trufanov. In 2 vol. Moscow: GEOTAR-Media, 2011; V. 1. 416 p. (In Russian)Ищенко К.Б., Эпидемиология, клиника и диагностика уротелиальных опухолей почечной лоханки и мочеточника: современное состояние проблемы. Злокачественные опухоли. 2016; 2 (18): 66–71. DOI: 10.18027/2224–5057–2016–2–66–71.Ishchenko K.B. Epidemiology, clinic and diagnostics of urothelial tumors of the renal pelvis and ureter: current state of the problem. Zlokachestvennie opukholi. 2016; 2 (18): 66–71. DOI: 10.18027/2224-5057-2016-2-66-71. (In Russian)Khan A.N. Transitional Cell Carcinoma Imaging. Medscape. 2016; Aug 21. https://emedicine.medscape.com/ article/381323-overview#a4Khan A.N. Transitional Cell Carcinoma Imaging. Medscape. 2016; Aug 21. https://emedicine.medscape.com/article/381323-overview#a4Kaza R.K., Ananthakrishnan L., Kambadakone A., Platt J.F. Update of Dual-Energy CT Applications in the Genitourinary Tract. Am. J. Roentgenol. 2017; 208: 1185–1192. DOI: 10.2214/AJR.16.17742.Kaza R.K., Ananthakrishnan L., Kambadakone A., Platt J.F. Update of Dual-Energy CT Applications in the Genitourinary Tract. Am. J. Roentgenol. 2017; 208: 1185–1192. DOI: 10.2214/AJR.16.17742.Халиков А.Д., Маковская А.И. Методика магнитно-резонансной урографии. Лучевая диагностика и терапия. 2014; 3 (5): 98–102.Khalikov A.D., Makovsky A.I. The technique of magnetic resonance urography. Luchevaya diagnostika i therapiya. 2014; 3 (5): 98–102. (In Russian)Терновой С.К., Аляев Ю.Г., Синицын В.Е. и др. Диагностические возможности и клиническое использование МР-урографии. Медицинская визуализация. 2001; 2: 72–77.Ternovoy S.K., Alyaev Yu.G., Sinitsyn V.Е. and others. Diagnostic capabilities and clinical use of MR-urography. Medical Visualization. 2001; 2: 72–77. (In Russian)Лопаткин Н.А., Мартов А.Г., Ергаков Д.В. Эндоскопические методы диагностики и лечения папиллярных опухолей верхних мочевыводящих путей. Урология. 2001; 3: 46–51.Lopatkin N.A., Martov A.G., Ergakov D.V. Endoscopic methods of diagnosis and treatment of papillary tumors of the upper urinary tract. Urologiya. 2001; 3: 46–51. (In Russian)Seisen T., Peyronnet B., Dominguez-Escrig J.L., Bruins H.M., Yuan C.Y., Babjuk M., Böhle A., Burger M., Compérat E.M., Cowan N.C., Kaasinen E., Palou J., van Rhijn B.W., Sylvester R.J., Zigeuner R., Shariat S.F., Rouprêt M. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephrourecterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol. 2016; 70 (6): 1052–1068. DOI: 10.1016/j.eururo.2016.07.01.Seisen T., Peyronnet B., Dominguez-Escrig J.L., Bruins H.M., Yuan C.Y., Babjuk M., Böhle A., Burger M., Compérat E.M., Cowan N.C., Kaasinen E., Palou J., van Rhijn B.W., Sylvester R.J., Zigeuner R., Shariat S.F., Rouprêt M. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephrourecterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol. 2016; 70 (6): 1052–1068. DOI: 10.1016/j.eururo.2016.07.01.

The authors declare that there are no conflicts of interest present.